Differentiating Scleroderma from other diseases: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Scleroderma}}
{{Scleroderma}}
{{CMG}}; {{AE}} {{MIR}}
{{CMG}}; {{AE}} {{MKA}}


==Overview==
==Overview==
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].


==Differentiating Scleroderma from Other Diseases==
OR
===== Differentiating scleroderma from other diseases that may cause [[arthritis]] and [[rash]]=====
 
<span style="font-size:85%">'''Abbreviations:'''
[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
'''ANA:''' [[Anti-nuclear antibody|Antinuclear antibody]], '''RF:''' [[Rheumatoid factor]], '''Anti-CCp:''' [[Anti-citrullinated protein antibody|Anti-cyclic citrullinated protein antibody]], '''Anti U1RNP:''' Anti-U1 ribonucleoprotein antibodies , '''Anti Sm :''' Anti-Sm antibodies, '''Anti Ro:''' Anti Ro antibody also called anti-Sjögren's-syndrome-related antigen A antibody, '''Anti-dsDNA:''' [[Anti-dsDNA antbodies|Anti-double stranded DNA]].</span><small>
 
{| class="wikitable"
==Differentiating X from other Diseases==
! colspan="2" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Disease
*[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
! colspan="5" align="center" style="background:#4479BA; color: #FFFFFF;" |Arthritis
*[Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" |Auto-antibodies
 
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Raynaud phenomenon
*As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Rash pattern
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Distinguishing/specific features
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" |Polyarthritis
! align="center" style="background:#4479BA; color: #FFFFFF;" |Tenderness
! align="center" style="background:#4479BA; color: #FFFFFF;" |Edema
! align="center" style="background:#4479BA; color: #FFFFFF;" |Deformity /Erosion
! align="center" style="background:#4479BA; color: #FFFFFF;" |Pattern
! align="center" style="background:#4479BA; color: #FFFFFF;" |ANA
! align="center" style="background:#4479BA; color: #FFFFFF;" |RF
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti-CCp
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti U1RNP
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti Sm
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti Ro
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti-dsDNA
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Systemic sclerosis]] (SSc)<ref name="pmid3361530">{{cite journal |vauthors=LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F |title=Scleroderma (systemic sclerosis): classification, subsets and pathogenesis |journal=J. Rheumatol. |volume=15 |issue=2 |pages=202–5 |year=1988 |pmid=3361530 |doi= |url=}}</ref>
| align="center" |<nowiki>+/-</nowiki>
| align="center" |<nowiki>+</nowiki>
| align="center" |<nowiki>+</nowiki>
| align="center" |<nowiki>+/-</nowiki>
| align="center" |Lower extremity
| align="center" |↑↑
| align="center" | -
| align="center" | -
| align="center" | -
| align="center" |↑
| align="center" | -
| align="center" |↑
| align="center" | +
|[[Hyperkeratosis]], [[edema]], and [[erythema]]
|[[Sclerodactyly]], [[Telangiectasias]], [[Calcinosis]], [[Malignant hypertension]], [[acute renal failure]]
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Systemic lupus erythematosus]]<ref name="pmid25074031">{{cite journal |vauthors=Ehmke TA, Cherian JJ, Wu ES, Jauregui JJ, Banerjee S, Mont MA |title=Treatment of osteonecrosis in systemic lupus erythematosus: a review |journal=Curr Rheumatol Rep |volume=16 |issue=9 |pages=441 |year=2014 |pmid=25074031 |doi=10.1007/s11926-014-0441-8 |url=}}</ref>
| align="center" |<nowiki>+</nowiki>
| align="center" |<nowiki>+</nowiki>
| align="center" |<nowiki>+</nowiki>
| align="center" |<nowiki>-</nowiki>
| align="center" |Small joints
| align="center" |↑
| align="center" |<nowiki>-</nowiki>
| align="center" |<nowiki>-</nowiki>
| align="center" | -
| align="center" |↑
| align="center" |↑
| align="center" | -
| align="center" |<nowiki>+</nowiki>
|[[Malar rash]] and [[photosensitivity]]
|
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Rheumatoid arthritis]]  ([[Rheumatoid arthritis|RA]])<ref name="pmid11567728">{{cite journal |vauthors=Lee DM, Weinblatt ME |title=Rheumatoid arthritis |journal=Lancet |volume=358 |issue=9285 |pages=903–11 |year=2001 |pmid=11567728 |doi=10.1016/S0140-6736(01)06075-5 |url=}}</ref>
| align="center" | +
| align="center" | +
| align="center" | +
| align="center" | +
| align="center" |Small and large joints
| align="center" |<nowiki>-</nowiki>
| align="center" |↑↑
| align="center" |↑↑
| align="center" |<nowiki>-</nowiki>
| align="center" |<nowiki>-</nowiki>
| align="center" | -
| align="center" | -
| align="center" | +
|[[Subcutaneous]] [[nodules]]
|Erosive [[arthropathy]]
|-
| colspan="2" align="center" style="background:#DCDCDC;" |Rhupus<ref name="pmid3382309">{{cite journal |vauthors=Panush RS, Edwards NL, Longley S, Webster E |title='Rhupus' syndrome |journal=Arch. Intern. Med. |volume=148 |issue=7 |pages=1633–6 |year=1988 |pmid=3382309 |doi= |url=}}</ref>
| align="center" | +
| align="center" | +
| align="center" | +
| align="center" | +
| align="center" |Small and large joints
| align="center" |↑
| align="center" |↑
| align="center" |↑
| align="center" |↑
| align="center" |↑
| align="center" |<nowiki>-</nowiki>
| align="center" |↑
| align="center" | +
|[[Malar rash]] and [[photosensitivity]]
|Erosive [[arthropathy]]
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Mixed connective tissue disease]] (MCTD)<ref name="pmid21959290">{{cite journal |vauthors=Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radić M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Matucci Cerinic M |title="To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity |journal=Semin. Arthritis Rheum. |volume=41 |issue=4 |pages=589–98 |year=2012 |pmid=21959290 |doi=10.1016/j.semarthrit.2011.07.010 |url=}}</ref>
| align="center" |<nowiki>-</nowiki>
| align="center" | -
| align="center" | -
| align="center" | +
| align="center" |Small and large joints
| align="center" |<nowiki>-</nowiki>
| align="center" |↑↑
| align="center" |↑
| align="center" | -
| align="center" | -
| align="center" | -
| align="center" | -
| align="center" | +
|Cutaneous eruptions, [[Gottron's papules|gottron’s papules]], photodistributed [[erythema]], [[Poikiloderma of civatte|poikiloderma]], and [[calcinosis cutis]]
|Overlapping features of SLE, [[systemic sclerosis]] (SSc), and [[polymyositis]] (PM) that lead to more than one diagnosis
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Undifferentiated connective tissue disease]] (UCTD)<ref name="pmid1757934">{{cite journal |vauthors=Alarcón GS, Williams GV, Singer JZ, Steen VD, Clegg DO, Paulus HE, Billingsley LM, Luggen ME, Polisson RP, Willkens RF |title=Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease |journal=J. Rheumatol. |volume=18 |issue=9 |pages=1332–9 |year=1991 |pmid=1757934 |doi= |url=}}</ref>
| align="center" | +
| align="center" | -
| align="center" | -
| align="center" | -
| align="center" |Lower extremity
| align="center" |↑
| align="center" |↑
| align="center" | -
| align="center" | -
| align="center" |↑
| align="center" | -
| align="center" | -
| align="center" | +
|[[Erythematous]] [[macules]], patches, or [[papules]] with delicate scale
|Multiple connective tissue diseases with no enough criteria for a single diagnosis
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Sjögren’s syndrome]]<ref name="pmid15485020">{{cite journal |vauthors=Roguedas AM, Misery L, Sassolas B, Le Masson G, Pennec YL, Youinou P |title=Cutaneous manifestations of primary Sjögren's syndrome are underestimated |journal=Clin. Exp. Rheumatol. |volume=22 |issue=5 |pages=632–6 |year=2004 |pmid=15485020 |doi= |url=}}</ref>
| align="center" |<nowiki>+/-</nowiki>
| align="center" |<nowiki>+/-</nowiki>
| align="center" | -
| align="center" | -
| align="center" |[[Lower extremity]], axiallary creases
| align="center" |↑
| align="center" | -
| align="center" | -
| align="center" | -
| align="center" |↑
| align="center" |↑
| align="center" | -
| align="center" | -
|[[Xerosis]], scaly skin, annular [[erythema]]


|[[Keratoconjunctivitis sicca]]
===Preferred Table===
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="4"  style="background: #4479BA; color: #FFFFFF; text-align: center;|Diseases
| colspan="6" rowspan="1"  style="background: #4479BA; color: #FFFFFF; text-align: center;|'''Clinical manifestations'''
! colspan="7" rowspan="2"  style="background: #4479BA; color: #FFFFFF; text-align: center;|Para-clinical findings
| colspan="1" rowspan="4"  style="background: #4479BA; color: #FFFFFF; text-align: center;|'''Gold standard'''
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;|Additional findings
|-
|-
| rowspan="3" align="center" style="background:#DCDCDC;" |Vasculitis
| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;|'''Symptoms'''
| align="center" style="background:#DCDCDC;" |[[Giant cell]]<ref name="pmid17031245">{{cite journal |vauthors=Bablekos GD, Michaelides SA, Karachalios GN, Nicolaou IN, Batistatou AK, Charalabopoulos KA |title=Pericardial involvement as an atypical manifestation of giant cell arteritis: report of a clinical case and literature review |journal=Am. J. Med. Sci. |volume=332 |issue=4 |pages=198–204 |year=2006 |pmid=17031245 |doi= |url=}}</ref>
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;|Physical examination
| align="center" | -
| align="center" |<nowiki>+</nowiki>
| align="center" |<nowiki>+</nowiki>
| align="center" | -
| align="center" |Distal extremity
| align="center" | -
| align="center" | -
| align="center" | -
| align="center" | -
| align="center" | -
| align="center" | -
| align="center" | -
| rowspan="3" align="center" | -
|Rare
|Involvement of cranial branches of arteries, visual loss
|-
|-
| align="center" style="background:#DCDCDC;" |[[Takayasu's arteritis|Takayasu]]<ref name="pmid12655">{{cite journal |vauthors=Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE |title=Takayasu's arteritis. Clinical study of 107 cases |journal=Am. Heart J. |volume=93 |issue=1 |pages=94–103 |year=1977 |pmid=12655 |doi= |url=}}</ref>
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;|Lab Findings
| align="center" |<nowiki>-</nowiki>
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;|Imaging
| align="center" | +/-
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;|Histopathology
| align="center" | +/-
|-
| align="center" | -
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Symptom 1
| align="center" |Transient extremity
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;|Symptom 2
| align="center" | -
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Symptom 3
| align="center" | -
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Physical exam 1
| align="center" | -
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;|Physical exam 2
| align="center" | -
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Physical exam 3
| align="center" | -
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Lab 1
| align="center" | -
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Lab 2
| align="center" | -
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Lab 3
|[[Erythema nodosum]], [[pyoderma gangrenosum]]
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Imaging 1
|Absent or weak peripheral pulse
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Imaging 2
! style="background: #4479BA; color: #FFFFFF; text-align: center;|Imaging 3
|-
|-
| align="center" style="background:#DCDCDC;" |[[Polyarteritis nodosa|Poly-arteritis nodosa]]<ref name="pmid20112401">{{cite journal |vauthors=Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, Mouthon L, Guillevin L |title=Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database |journal=Arthritis Rheum. |volume=62 |issue=2 |pages=616–26 |year=2010 |pmid=20112401 |doi=10.1002/art.27240 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Differential Diagnosis 1
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | +/-
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |General and mild
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
|[[Tenderness|Tender]] [[Erythematous rash|erythematous nodules]], [[purpura]], [[livedo reticularis]], [[bullous]] or [[Vesicular|vesicular eruption]]
| style="background: #F5F5F5; padding: 5px;" |
|[[Testicular pain]] or [[tenderness]] and [[neuropathies]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Behçet's Syndrome|Behçet’s syndrome]]<ref name="pmid11760398">{{cite journal |vauthors=Tunç R, Uluhan A, Melikoğlu M, Ozyazgan Y, Ozdoğan H, Yazici H |title=A reassessment of the International Study Group criteria for the diagnosis (classification) of Behçet's syndrome |journal=Clin. Exp. Rheumatol. |volume=19 |issue=5 Suppl 24 |pages=S45–7 |year=2001 |pmid=11760398 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Differential Diagnosis 2
| align="center" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |medium and large joints
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
|Recurrent and usually painful [[mucocutaneous]] ulcers, [[Acneiform eruption|acneiform]] [[lesions]], papulo-vesiculo-[[Pustular rash|pustular]] eruptions, superficial [[thrombophlebitis]]
| style="background: #F5F5F5; padding: 5px;" |
|Male dominancy
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Kikuchi's Disease|Kikuchi’s disease]]<ref name="pmid16538388">{{cite journal |vauthors=Kucukardali Y, Solmazgul E, Kunter E, Oncul O, Yildirim S, Kaplan M |title=Kikuchi-Fujimoto Disease: analysis of 244 cases |journal=Clin. Rheumatol. |volume=26 |issue=1 |pages=50–4 |year=2007 |pmid=16538388 |doi=10.1007/s10067-006-0230-5 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Differential Diagnosis 3
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |medium and large joints
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |↑/↓
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
|Transient skin [[rashes]], [[malar rash]], [[Macule|erythematous macules]], patches, [[papules]], or [[plaques]]
| style="background: #F5F5F5; padding: 5px;" |
|May be associated with SLE
| style="background: #F5F5F5; padding: 5px;" |
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!Diseases
!Symptom 1
! colspan="1" rowspan="1" |Symptom 2
!Symptom 3
!Physical exam 1
! colspan="1" rowspan="1" |Physical exam 2
!Physical exam 3
!Lab 1
!Lab 2
!Lab 3
!Imaging 1
!Imaging 2
!Imaging 3
!Histopathology
|'''Gold standard'''
!Additional findings
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Serum sickness]]<ref name="pmid3564980">{{cite journal |vauthors=Kunnamo I, Kallio P, Pelkonen P, Viander M |title=Serum-sickness-like disease is a common cause of acute arthritis in children |journal=Acta Paediatr Scand |volume=75 |issue=6 |pages=964–9 |year=1986 |pmid=3564980 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Differential Diagnosis 4
| align="center" | +
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |General
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
|[[Pruritic disorders|Pruritic rash]], [[urticaria]] and/or serpiginous [[Rash|macular rash]]
| style="background: #F5F5F5; padding: 5px;" |
|Self-limited
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Psoriatic arthritis]]<ref name="pmid8076388">{{cite journal |vauthors=Oriente P, Biondi-Oriente C, Scarpa R |title=Psoriatic arthritis. Clinical manifestations |journal=Baillieres Clin Rheumatol |volume=8 |issue=2 |pages=277–94 |year=1994 |pmid=8076388 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Differential Diagnosis 5
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |Small and large joints
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
|[[Psoriasis]] and [[onychodystrophy]]
| style="background: #F5F5F5; padding: 5px;" |
|[[Dactylitis]] (sausage digits)
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Parvovirus B19|Human parvovirus B19 infection]]<ref name="pmid17384979">{{cite journal |vauthors=Kaufmann J, Buccola JM, Stead W, Rowley C, Wong M, Bates CK |title=Secondary symptomatic parvovirus B19 infection in a healthy adult |journal=J Gen Intern Med |volume=22 |issue=6 |pages=877–8 |year=2007 |pmid=17384979 |pmc=2219874 |doi=10.1007/s11606-007-0173-9 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Differential Diagnosis 6
| align="center" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" |Small joints
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
| align="center" | -
| style="background: #F5F5F5; padding: 5px;" |
|[[Erythematous rash|Erythematous rashes]]
| style="background: #F5F5F5; padding: 5px;" |
|Rare in adults, [[Fifth disease|fifth's disease]] in children
| style="background: #F5F5F5; padding: 5px;" |
|}
|}
</small>
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Up-To-Date]]
{{WH}}
[[Category:Primary care]]
{{WS}}
[[Category:Medicine]]
[[Category: (name of the system)]]
[[Category:Dermatology]]
[[Category:Rheumatology]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Revision as of 14:08, 19 April 2018

Scleroderma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Scleroderma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Differentiating Scleroderma from other diseases On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Differentiating Scleroderma from other diseases

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Differentiating Scleroderma from other diseases

CDC on Differentiating Scleroderma from other diseases

Differentiating Scleroderma from other diseases in the news

Blogs on Differentiating Scleroderma from other diseases

Directions to Hospitals Treating Scleroderma

Risk calculators and risk factors for Differentiating Scleroderma from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Overview

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

OR

[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].

Differentiating X from other Diseases

  • [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
  • [Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
  • As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].

Preferred Table

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Lab 1 Lab 2 Lab 3 Imaging 1 Imaging 2 Imaging 3
Differential Diagnosis 1
Differential Diagnosis 2
Differential Diagnosis 3
Diseases Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Lab 1 Lab 2 Lab 3 Imaging 1 Imaging 2 Imaging 3 Histopathology Gold standard Additional findings
Differential Diagnosis 4
Differential Diagnosis 5
Differential Diagnosis 6

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Differentiating_Scleroderma_from_other_diseases&oldid=1464139"